3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
9
Sexual Dysfunction, Physiological
1
Prostatic Intraepithelial Neoplasia
1
Prostatic Hyperplasia
1
Infertility
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Dutasteride
3
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
2
proxalutamide
1
polyphenon E
1
mirabegron
1
TroVax
1
Transurethral Resection of Prostate
1
Transurethral Resection of Bladder
1
Therapeutics
1
Tamsulosin
1
Standard of Care
1
Risedronic Acid
1
Radiotherapy
1
Psychiatric Rehabilitation
1
Prostatectomy
1
Papaverine
1
Oxygen
1
Nitrous Oxide
1
Needles
1
Microspheres
1
Lycopene
1
Levofloxacin
1
Finasteride
1
Electroacupuncture
1
Doxazosin
1
Docetaxel
1
Diclofenac
1
Dexmedetomidine
1
Cystoscopy
1
Celecoxib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Prostatic Hyperplasia
×
Finasteride
×
Clear all
NCT06001619
2023-08-21
PROMED
Turku University Hospital
Phase 4
Recruiting
100 enrolled